Christoph Lengauer - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Christoph Lengauer’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
Investor type
Country
City/Area
Stages
fir***@***.com
Available after registration.
Markets
Past investmentsChristoph Lengauer is a Venture Capital, Accelerator, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics, Constellation Pharmaceuticals, Jounce Therapeutics, Motus Therapeutics, PanOptica, Warp Drive Bio, Editas Medicine, Ember Therapeutics, MOMA Therapeutics, Relay Therapeutics, Decibel Therapeutics, CytomX Therapeutics, Topica PharmaceuticalsCibiem, Inc., Alcresta, Rhythm Metabolic, Agios Pharmaceuticals, Rheos Medicines, Lotus Tissue Repair, Bluebird Bio, Corvia Medical, Afferent Pharmaceuticals, Foundation Medicine, Fulcrum Therapeutics, Voyager Therapeutics, Seventh Sense Biosystems, Maze Therapeutics, Neon Therapeutics, TARIS Biomedical, NinePoint Medical, Asher Bio, MyoKardia, Thrive Earlier Detection, Celsius Therapeutics, Igenica, Cedilla Therapeutics, Casma Therapeutics, Edimer Pharmaceuticals, Pliant Therapeutics, Sesen Bio, Inc., Element Science, Insitro, Soffio Medical, Revolution Medicines, Faze Medicines, Ambys Medicines, Global Blood Therapeutics, Kala Pharmaceuticals, Rhythm Pharmaceuticals, Cancer Research UK (CRUK), Nurix Therapeutics, Tango Therapeutics, SAGE Therapeutics, Allena Pharmaceuticals, . Over time, Christoph Lengauer has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Christoph Lengauer is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Regenerative Medicine, Drug Discovery, Wellness, Women Founded, Healthcare Innovation, Life Science, Engineering, Portfolio Management, Medical Technologies, Skill Assessment, Strategic Planning, Venture Fundraising, Finance, Bioinformatics, Biotechnology, Drug Development, Genomics, Clinical Trials, Research, Consulting, Personalized Medicine, Technology Transfer, Health Diagnostics, Digital Health, Regulatory Compliance, Medical, Information Technology, B2B, Therapeutics, Pharmaceuticals, Biometrics may find it worthwhile to explore potential connections with Christoph Lengauer, as their portfolio suggests a familiarity and interest in this area.
Understanding Christoph Lengauer’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
